Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Dáil Éireann díospóireacht -
Tuesday, 29 Jun 1999

Vol. 507 No. 2

Written Answers. - Drugs Refund Scheme.

Deirdre Clune

Ceist:

170 Ms Clune asked the Minister for Health and Children if his attention has been drawn to the large medical expenses experienced by the families of those who suffer from asthma; the proposals, if any, he has to alleviate expenses; and if he will make a statement on the matter. [16746/99]

Persons who are unable, without undue hardship, to arrange for the provision of medical services for themselves and their dependants may be entitled to a medical card. In determining eligibility, the local health board will have regard to the financial circumstances and medical needs of the applicant. In this regard, income guidelines are used by health boards to assist in determining a person's eligibility. These guidelines are not statutorily binding and even though a person's income exceeds the guidelines, the person may still be awarded a medical card if the chief executive officer considers that the person's medical needs or other circumstances would justify this. Medical cards may also be issued to individual family members on this basis. Eligibility for a medical card is solely a matter for the chief executive officer of the relevant health board to decide.

There are also schemes available which provide financial assistance towards the cost of prescribed drugs and medicines to people who do not have medical cards. For example, persons suffering from an ongoing condition can avail of the drug cost subsidisation scheme which caters for people who are certified as having a medical condition with a regular and ongoing requirement for prescribed drugs and medicines. Persons who qualify for inclusion in this scheme do not have to pay more than £32 in any month on prescribed medication. Under the drug refund scheme, families and individuals pay the full cost of their prescription medicines and may, at the end of the quarter, claim reimbursement from their health board for expenditure over £90 in that calendar quarter.
With effect from 1 July 1999, the new drug payment scheme will replace the drug cost subsidisation scheme and the drug refund scheme with a monthly threshold of £42. The new scheme will effectively merge the best elements of the two existing schemes and is designed to significantly improve the cash flow situations of families and individuals incurring ongoing expenditure on medicines. Under the new scheme, no individual or family will have to pay more than £42 per month for approved prescribed drugs and medicines for use in that month. For the first time, families and individuals will be able to budget for the cost of medicines. As the scheme will operate on a monthly rather than a quarterly basis, it has advantages over the drug refund scheme. Furthermore, unlike the drug cost subsidisation scheme, there are no qualifying criteria for inclusion in the new drug payment scheme.
I am satisfied that appropriate and comprehensive support is being provided by the State to those with ongoing medical expenses such as people with asthma.

John Dennehy

Ceist:

171 Mr. Dennehy asked the Minister for Health and Children if he will permit treatment for sufferers of moebius syndrome, a rare disease affecting the nervous system, to be covered by the terms of the general medical scheme. [16747/99]

Persons who are unable, without undue hardship, to arrange for the provision of medical services for themselves and their dependants may be entitled to a medical card. In determining eligibility for medical cards, health boards have regard to the financial circumstances and medical needs of the applicant. Income guidelines are used by health boards to assist in determining a person's eligibility. These guidelines are not statutorily binding and even though a person's income exceeds the guidelines, the person may still be awarded a medical card if the chief executive officer considers that the person's medical needs or other circumstances would justify this. Medical cards may also be issued to individual family members on this basis. Eligibility for a medical card is solely a matter for the chief executive officer of the relevant health board to decide.

In view of this special provision, I do not think that it is justifiable to extend an automatic entitlement to a medical card to any specific group without any reference to their means, particularly in view of the very many areas of pressing need in the health services and the limited resources available to meet them. I am satisfied that appropriate and comprehensive support is being provided by the State, through other schemes, to those with ongoing medical expenses who do not have medical cards.

For example, persons suffering from an ongoing condition can avail of the drug cost subsidisation scheme which caters for people who are certified as having a medical condition with a regular and ongoing requirement for prescribed drugs and medicines. Persons who qualify for inclusion in this scheme do not have to pay more than £32 in any month on prescribed medication. Under the drug refund scheme, families and individuals pay the full cost of their prescription medicines and may, at the end of the quarter, claim reimbursement from their health board for expenditure over £90 in that calendar quarter.

As the Deputy will be aware, with effect from 1 July 1999, the new drug payment scheme will replace the drug cost subsidisation scheme and the drug refund scheme with a monthly threshold of £42. The new scheme will effectively merge the best elements of the two existing schemes and is designed to significantly improve the cash flow situations of families and individuals incurring ongoing expenditure on medicines. Under the new scheme, no individual or family will have to pay more than £42 per month for approved prescribed drugs and medicines for use in that month. For the first time, families and individuals will be able to budget for the cost of medicines. Furthermore, unlike the drug cost subsidisation scheme, there are no qualifying criteria for inclusion in the new drug payment scheme.
Barr
Roinn